FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2894524920> ?p ?o ?g. }

• W2894524920 endingPage "875" @default.
• W2894524920 startingPage "865" @default.
• W2894524920 abstract "Non-small-cell lung cancer (NSCLC) is recognized as the most common malignant disease worldwide and combination treatment is recommended as its first line therapy. As a Ph2 clinical product, Ginsenoside H dripping pills (GH) is proposed as an adjuvant of chemotherapy. In the present study, we utilized a postoperative model to evaluate the efficacy of GH on the functions of anti-recurrence and improvement of life quality when combined with chemotherapeutic drug cyclophosphamide (CTX). Specifically, the anti-recurrence effect was evaluated by tumor inhibiting rate and the improvement of life quality was evaluated by the remission of splenomegaly and emaciation. The underlying mechanisms were explored via quantitative real time-PCR, Elisa and IHC staining. Results showed that GH had a synergy when combined with CTX against tumor recurrence, significantly improved the life quality of postoperative patients via remitting splenomegaly and emaciation. H&E staining showed that GH could increase the number of splenic T cells, which were inhibited after CTX administration. Furthermore, the reversion of Th1/Th2 shift, which had been verified by different methods, may account for one of the mechanisms of the synergy. All these results indicated Ginsenoside H dripping pills as a promising adjuvant for postoperative chemotherapy of NSCLC." @default.
• W2894524920 created "2018-10-05" @default.
• W2894524920 creator A5033101793 @default.
• W2894524920 creator A5033187394 @default.
• W2894524920 creator A5039057617 @default.
• W2894524920 creator A5041754862 @default.
• W2894524920 creator A5058493921 @default.
• W2894524920 creator A5058555021 @default.
• W2894524920 creator A5058775119 @default.
• W2894524920 date "2018-12-01" @default.
• W2894524920 modified "2023-10-16" @default.
• W2894524920 title "Combination of Ginsenoside H dripping pills and cyclophosphamide improve paraneoplastic syndrome and inhibit postoperative recurrence via the reversion of Th1/Th2 shift" @default.
• W2894524920 cites W1516701418 @default.
• W2894524920 cites W1779444278 @default.
• W2894524920 cites W1972184110 @default.
• W2894524920 cites W1982861439 @default.
• W2894524920 cites W1988790936 @default.
• W2894524920 cites W2002580210 @default.
• W2894524920 cites W2015346116 @default.
• W2894524920 cites W2029602014 @default.
• W2894524920 cites W2045341669 @default.
• W2894524920 cites W2059498834 @default.
• W2894524920 cites W2060702086 @default.
• W2894524920 cites W2083854941 @default.
• W2894524920 cites W2117051514 @default.
• W2894524920 cites W2133291915 @default.
• W2894524920 cites W2150432858 @default.
• W2894524920 cites W2164790671 @default.
• W2894524920 cites W2171139285 @default.
• W2894524920 cites W2186495104 @default.
• W2894524920 cites W2272984102 @default.
• W2894524920 cites W2323751645 @default.
• W2894524920 cites W2522633190 @default.
• W2894524920 cites W2531702976 @default.
• W2894524920 cites W259163314 @default.
• W2894524920 cites W2597798036 @default.
• W2894524920 doi "https://doi.org/10.1016/j.biopha.2018.09.085" @default.
• W2894524920 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30372898" @default.
• W2894524920 hasPublicationYear "2018" @default.
• W2894524920 type Work @default.
• W2894524920 sameAs 2894524920 @default.
• W2894524920 citedByCount "7" @default.
• W2894524920 countsByYear W28945249202020 @default.
• W2894524920 countsByYear W28945249202021 @default.
• W2894524920 countsByYear W28945249202022 @default.
• W2894524920 countsByYear W28945249202023 @default.
• W2894524920 crossrefType "journal-article" @default.
• W2894524920 hasAuthorship W2894524920A5033101793 @default.
• W2894524920 hasAuthorship W2894524920A5033187394 @default.
• W2894524920 hasAuthorship W2894524920A5039057617 @default.
• W2894524920 hasAuthorship W2894524920A5041754862 @default.
• W2894524920 hasAuthorship W2894524920A5058493921 @default.
• W2894524920 hasAuthorship W2894524920A5058555021 @default.
• W2894524920 hasAuthorship W2894524920A5058775119 @default.
• W2894524920 hasBestOaLocation W28945249201 @default.
• W2894524920 hasConcept C104317684 @default.
• W2894524920 hasConcept C126322002 @default.
• W2894524920 hasConcept C127716648 @default.
• W2894524920 hasConcept C143998085 @default.
• W2894524920 hasConcept C185592680 @default.
• W2894524920 hasConcept C2775859590 @default.
• W2894524920 hasConcept C2776694085 @default.
• W2894524920 hasConcept C2776755627 @default.
• W2894524920 hasConcept C2777863537 @default.
• W2894524920 hasConcept C2780835546 @default.
• W2894524920 hasConcept C55493867 @default.
• W2894524920 hasConcept C70883133 @default.
• W2894524920 hasConcept C71924100 @default.
• W2894524920 hasConcept C81603835 @default.
• W2894524920 hasConcept C90924648 @default.
• W2894524920 hasConcept C98274493 @default.
• W2894524920 hasConceptScore W2894524920C104317684 @default.
• W2894524920 hasConceptScore W2894524920C126322002 @default.
• W2894524920 hasConceptScore W2894524920C127716648 @default.
• W2894524920 hasConceptScore W2894524920C143998085 @default.
• W2894524920 hasConceptScore W2894524920C185592680 @default.
• W2894524920 hasConceptScore W2894524920C2775859590 @default.
• W2894524920 hasConceptScore W2894524920C2776694085 @default.
• W2894524920 hasConceptScore W2894524920C2776755627 @default.
• W2894524920 hasConceptScore W2894524920C2777863537 @default.
• W2894524920 hasConceptScore W2894524920C2780835546 @default.
• W2894524920 hasConceptScore W2894524920C55493867 @default.
• W2894524920 hasConceptScore W2894524920C70883133 @default.
• W2894524920 hasConceptScore W2894524920C71924100 @default.
• W2894524920 hasConceptScore W2894524920C81603835 @default.
• W2894524920 hasConceptScore W2894524920C90924648 @default.
• W2894524920 hasConceptScore W2894524920C98274493 @default.
• W2894524920 hasLocation W28945249201 @default.
• W2894524920 hasLocation W28945249202 @default.
• W2894524920 hasOpenAccess W2894524920 @default.
• W2894524920 hasPrimaryLocation W28945249201 @default.
• W2894524920 hasRelatedWork W1967484801 @default.
• W2894524920 hasRelatedWork W1984881470 @default.
• W2894524920 hasRelatedWork W2034463319 @default.
• W2894524920 hasRelatedWork W2051287676 @default.
• W2894524920 hasRelatedWork W2078074588 @default.
• W2894524920 hasRelatedWork W2132261997 @default.
• W2894524920 hasRelatedWork W2153230751 @default.

• next